{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:26:11Z","timestamp":1770294371374,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T00:00:00Z","timestamp":1528243200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00259-018-4061-9","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T14:00:30Z","timestamp":1528293630000},"page":"2093-2102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Can integrated 18F-FDG PET\/MR replace sentinel lymph node resection in malignant melanoma?"],"prefix":"10.1007","volume":"45","author":[{"given":"Benedikt Michael","family":"Schaarschmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Grueneisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Stebner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Klode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingo","family":"Stoffels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lale","family":"Umutlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Schadendorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Heusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Antoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten Dirk","family":"P\u00f6ppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,6]]},"reference":[{"key":"4061_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/00000658-199110000-00013","volume":"214","author":"DL Morton","year":"1991","unstructured":"Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg. 1991;214:491\u2013501.","journal-title":"Ann Surg"},{"key":"4061_CR2","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong S-J, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American joint committee on Cancer melanoma staging system. JCO. 2001;19:3622\u201334.","journal-title":"JCO"},{"key":"4061_CR3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","volume":"242","author":"DL Morton","year":"2005","unstructured":"Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, et al. Sentinel node biopsy for early-stage melanoma. Ann Surg. 2005;242:302\u201313.","journal-title":"Ann Surg"},{"key":"4061_CR4","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1056\/NEJMoa060992","volume":"355","author":"DL Morton","year":"2006","unstructured":"Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307\u201317.","journal-title":"N Engl J Med"},{"key":"4061_CR5","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1200\/JCO.2010.31.6760","volume":"29","author":"APT Ploeg van der","year":"2011","unstructured":"van der Ploeg APT, van Akkooi ACJ, Rutkowski P, Nowecki ZI, Michej W, Mitra A, et al. Prognosis in patients with sentinel node\u2013positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. JCO. 2011;29:2206\u201314.","journal-title":"JCO."},{"key":"4061_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599\u2013609.","journal-title":"N Engl J Med"},{"key":"4061_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejca.2009.10.032","volume":"46","author":"C Garbe","year":"2010","unstructured":"Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, Spatz A, et al. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur J Cancer. 2010;46:270\u201383.","journal-title":"Eur J Cancer"},{"key":"4061_CR8","first-page":"563","volume":"11","author":"A Pflugfelder","year":"2013","unstructured":"Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, et al. S3-guideline \u201cdiagnosis, therapy and follow-up of melanoma\u201d \u2013 short version. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2013;11:563\u2013602.","journal-title":"JDDG: Journal der Deutschen Dermatologischen Gesellschaft"},{"key":"4061_CR9","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1245\/s10434-017-6267-7","volume":"25","author":"SL Wong","year":"2018","unstructured":"Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, et al. Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology clinical practice guideline update. Ann Surg Oncol. 2018;25:356\u201377.","journal-title":"Ann Surg Oncol"},{"key":"4061_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/jso.22043","volume":"104","author":"OE Nieweg","year":"2011","unstructured":"Nieweg OE, Veenstra HJ. False-negative sentinel node biopsy in melanoma. J Surg Oncol. 2011;104:709\u201310.","journal-title":"J Surg Oncol"},{"key":"4061_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/jso.21967","volume":"104","author":"HJ Veenstra","year":"2011","unstructured":"Veenstra HJ, Wouters MJWM, Kroon BBR, Olmos RAV, Nieweg OE. Less false-negative sentinel node procedures in melanoma patients with experience and proper collaboration. J Surg Oncol. 2011;104:454\u20137.","journal-title":"J Surg Oncol"},{"key":"4061_CR12","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1001\/jama.290.24.3199","volume":"290","author":"G Antoch","year":"2003","unstructured":"Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, et al. Whole-body dual-modality PET\/CT and whole-body MRI for tumor staging in oncology. JAMA. 2003;290:3199\u2013206.","journal-title":"JAMA"},{"key":"4061_CR13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1148\/radiol.2292021598","volume":"229","author":"G Antoch","year":"2003","unstructured":"Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, et al. Non-small cell lung cancer: dual-modality PET\/CT in preoperative staging. Radiology. 2003;229:526\u201333.","journal-title":"Radiology"},{"key":"4061_CR14","doi-asserted-by":"crossref","unstructured":"Oude Ophuis CMC, Koppert L (Linetta) B, de Mony\u00e9 C, van Deurzen CHM, Koljenovi\u0107 S, van Akkooi ACJ, et al. Gamma probe and ultrasound guided fine needle aspiration cytology of the sentinel node (GULF) trial - overview of the literature, pilot and study protocol. BMC Cancer [Internet]. 2017 [cited 2017 Oct 30];17. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5389093\/ .","DOI":"10.1186\/s12885-017-3363-9"},{"key":"4061_CR15","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jacr.2008.02.022","volume":"5","author":"RH El-Maraghi","year":"2008","unstructured":"El-Maraghi RH, Kielar AZ. PET vs sentinel lymph node biopsy for staging melanoma: a patient intervention, comparison, outcome analysis. J Am Coll Radiol. 2008;5:924\u201331.","journal-title":"J Am Coll Radiol"},{"key":"4061_CR16","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/CMR.0b013e32830b363b","volume":"18","author":"B Singh","year":"2008","unstructured":"Singh B, Ezziddin S, Palmedo H, Reinhardt M, Strunk H, T\u00fcting T, et al. Preoperative 18F-FDG-PET\/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma. Melanoma Res. 2008;18:346\u201352.","journal-title":"Melanoma Res"},{"key":"4061_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamaoncol.2015.3664","volume":"2","author":"BY Scheier","year":"2016","unstructured":"Scheier BY, Lao CD, Kidwell KM, Redman BG. Use of preoperative PET\/CT staging in sentinel lymph node\u2013positive melanoma. JAMA Oncol. 2016;2:136\u20137.","journal-title":"JAMA Oncol"},{"key":"4061_CR18","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1258\/ar.2012.110635","volume":"53","author":"C Riegger","year":"2012","unstructured":"Riegger C, Koeninger A, Hartung V, Otterbach F, Kimmig R, Forsting M, et al. Comparison of the diagnostic value of FDG-PET\/CT and axillary ultrasound for the detection of lymph node metastases in breast Cancer patients. Acta Radiol. 2012;53:1092\u20138.","journal-title":"Acta Radiol"},{"key":"4061_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1148\/radiol.11110639","volume":"262","author":"AM Scaranelo","year":"2012","unstructured":"Scaranelo AM, Eiada R, Jacks LM, Kulkarni SR, Crystal P. Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis: study of reproducibility and reliability. Radiology. 2012;262:425\u201334.","journal-title":"Radiology"},{"key":"4061_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1148\/radiol.14141167","volume":"275","author":"R-J Schipper","year":"2015","unstructured":"Schipper R-J, Paiman M-L, Beets-Tan RGH, Nelemans PJ, de Vries B, Heuts EM, et al. Diagnostic performance of dedicated axillary T2- and diffusion-weighted MR imaging for nodal staging in breast cancer. Radiology. 2015;275:345\u201355.","journal-title":"Radiology"},{"key":"4061_CR21","doi-asserted-by":"crossref","unstructured":"van Nijnatten TJA, Goorts B, V\u00f6\u00f6 S, de Boer M, Kooreman LFS, Heuts EM, et al. Added value of dedicated axillary hybrid 18F-FDG PET\/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study. Eur J Nucl Med Mol Imaging. 2017:1\u20138.","DOI":"10.1007\/s00259-017-3823-0"},{"key":"4061_CR22","doi-asserted-by":"crossref","unstructured":"Grueneisen J, Beiderwellen K, Heusch P, Buderath P, Aktas B, Gratz M, et al. Correlation of standardized uptake value and apparent diffusion coefficient in integrated whole-body PET\/MRI of primary and recurrent cervical cancer. PLoS One [Internet]. 2014 [cited 2017 Sep 6];9. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4013042\/ .","DOI":"10.1371\/journal.pone.0096751"},{"key":"4061_CR23","doi-asserted-by":"crossref","unstructured":"Schaarschmidt BM, Buchbender C, Nensa F, Grueneien J, Gomez B, K\u00f6hler J, et al. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET\/MRI. PLoS One [Internet]. 2015 [cited 2017 Aug 7];10. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4289066\/ .","DOI":"10.1371\/journal.pone.0116277"},{"key":"4061_CR24","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/2012.jama.11030","volume":"308","author":"I Stoffels","year":"2012","unstructured":"Stoffels I, Boy C, P\u00f6ppel T, Kuhn J, Kl\u00f6tgen K, Dissemond J, et al. Association between sentinel lymph node excision with or without preoperative SPECT\/CT and metastatic node detection and disease-free survival in melanoma. JAMA. 2012;308:1007\u201314.","journal-title":"JAMA"},{"key":"4061_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/CMR.0b013e3282f702bf","volume":"18","author":"C Garbe","year":"2008","unstructured":"Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, et al. Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting. Melanoma Res. 2008;18:152\u201360.","journal-title":"Melanoma Res"},{"key":"4061_CR26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.1468-3083.2010.03786.x","volume":"25","author":"I Stoffels","year":"2011","unstructured":"Stoffels I, Dissemond J, K\u00f6rber A, Hillen U, Poeppel T, Schadendorf D, et al. Reliability and cost-effectiveness of sentinel lymph node excision under local anaesthesia versus general anaesthesia for malignant melanoma: a retrospective analysis in 300 patients with malignant melanoma AJCC stages I and II. J Eur Acad Dermatol Venereol. 2011;25:306\u201310.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4061_CR27","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/j.1468-3083.2010.03954.x","volume":"25","author":"J Klode","year":"2011","unstructured":"Klode J, Poeppel T, Boy C, Mueller S, Schadendorf D, K\u00f6rber A, et al. Advantages of preoperative hybrid SPECT\/CT in detection of sentinel lymph nodes in cutaneous head and neck malignancies. J Eur Acad Dermatol Venereol. 2011;25:1213\u201321.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4061_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ejso.2009.10.007","volume":"36","author":"L Barthelmes","year":"2010","unstructured":"Barthelmes L, Goyal A, Newcombe RG, McNeill F, Mansel RE. Adverse reactions to patent blue V dye \u2013 the NEW START and ALMANAC experience. European Journal of Surgical Oncology (EJSO). 2010;36:399\u2013403.","journal-title":"European Journal of Surgical Oncology (EJSO)"},{"key":"4061_CR29","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/annonc\/mdl176","volume":"17","author":"ACJ Akkooi van","year":"2006","unstructured":"van Akkooi ACJ, de Wilt JHW, Verhoef C, Schmitz PIM, van Geel AN, Eggermont AMM, et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Oncol. 2006;17:1578\u201385.","journal-title":"Ann Oncol"},{"key":"4061_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ultrasmedbio.2012.08.024","volume":"39","author":"T Hinz","year":"2013","unstructured":"Hinz T, Voth H, Ahmadzadehfar H, Hoeller T, Wenzel J, Bieber T, et al. Role of high-resolution ultrasound and PET\/CT imaging for preoperative characterization of sentinel lymph nodes in cutaneous melanoma. Ultrasound Med Biol. 2013;39:30\u20136.","journal-title":"Ultrasound Med Biol"},{"key":"4061_CR31","doi-asserted-by":"publisher","first-page":"317ra199","DOI":"10.1126\/scitranslmed.aad1278","volume":"7","author":"I Stoffels","year":"2015","unstructured":"Stoffels I, Morscher S, Helfrich I, Hillen U, Leyh J, Burton NC, et al. Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging. Sci Transl Med. 2015;7:317ra199.","journal-title":"Sci Transl Med"},{"key":"4061_CR32","first-page":"1420","volume":"34","author":"LS Gritters","year":"1993","unstructured":"Gritters LS, Francis IR, Zasadny KR, Wahl RL. Initial assessment of positron emission tomography using 2-Fluorine-18-Fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. J Nucl Med. 1993;34:1420\u20137.","journal-title":"J Nucl Med"},{"key":"4061_CR33","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1148\/radiology.195.3.7753998","volume":"195","author":"HC Steinert","year":"1995","unstructured":"Steinert HC, Huch B\u00f6ni RA, Buck A, B\u00f6ni R, Berthold T, Marincek B, et al. Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 1995;195:705\u20139.","journal-title":"Radiology"},{"key":"4061_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jso.1102","volume":"77","author":"JD Wagner","year":"2001","unstructured":"Wagner JD, Schauwecker DS, Davidson D, Wenck S, Jung S-H, Hutchins G. FDG\u2013PET sensitivity for melanoma lymph node metastases is dependent on tumor volume. J Surg Oncol. 2001;77:237\u201342.","journal-title":"J Surg Oncol"},{"key":"4061_CR35","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/00008390-200404000-00011","volume":"14","author":"AM Fink","year":"2004","unstructured":"Fink AM, Holle-Robatsch S, Herzog N, Mirzaei S, Rappersberger K, Lilgenau N, et al. Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II. Melanoma Res. 2004;14:141\u20135.","journal-title":"Melanoma Res"},{"key":"4061_CR36","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.0007-0963.2004.05870.x","volume":"150","author":"J Hafner","year":"2004","unstructured":"Hafner J, Schmid MH, Kempf W, Burg G, K\u00fcnzi W, Meuli-Simmen C, et al. Baseline staging in cutaneous malignant melanoma. Br J Dermatol. 2004;150:677\u201386.","journal-title":"Br J Dermatol"},{"key":"4061_CR37","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/cncr.21189","volume":"104","author":"JD Wagner","year":"2005","unstructured":"Wagner JD, Schauwecker D, Davidson D, Logan T, Coleman JJ, Hutchins G, et al. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma. Cancer. 2005;104:570\u20139.","journal-title":"Cancer"},{"key":"4061_CR38","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1001\/archsurg.141.3.284","volume":"141","author":"PB Clark","year":"2006","unstructured":"Clark PB, Soo V, Kraas J, Shen P, Levine EA. Futility of Fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma. Arch Surg. 2006;141:284\u20138.","journal-title":"Arch Surg"},{"issue":"2","key":"4061_CR39","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2967\/jnumed.117.196303","volume":"59","author":"Hannah Lockau","year":"2017","unstructured":"Lockau HH, Neuschmelting V, Ogirala A, Vilaseca A, Grimm J. Dynamic 18F-FDG PET- Lymphography for in vivo identification of lymph node metastases in murine melanoma. J Nucl Med. 2017; https:\/\/doi.org\/10.2967\/jnumed.117.196303 .","journal-title":"Journal of Nuclear Medicine"},{"key":"4061_CR40","doi-asserted-by":"publisher","first-page":"450","DOI":"10.6004\/jnccn.2016.0051","volume":"14","author":"DG Coit","year":"2016","unstructured":"Coit DG, Thompson JA, Algazi A, Andtbacka R, Bichakjian CK, Carson WE, et al. Melanoma, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2016;14:450\u201373.","journal-title":"J Natl Compr Cancer Netw"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-018-4061-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4061-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-018-4061-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T03:43:54Z","timestamp":1661399034000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-018-4061-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,6]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["4061"],"URL":"https:\/\/doi.org\/10.1007\/s00259-018-4061-9","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,6]]},"assertion":[{"value":"22 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Benedikt M. Schaarschmidt is a stockholder for Bayer AG, General Electric, Siemens AG, Siemencs Healthineers AG, TEVA Pharmaceuticals. All other authors declare that they have no conflict of interest. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}